{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:58:51Z","timestamp":1784213931690,"version":"3.55.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtct.2025.12.991","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:29:06Z","timestamp":1767025746000},"page":"518-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tregs in Allogeneic Hematopoietic Stem Cell Transplantation: Suppressing Graft-Versus-Host Disease while Preserving Graft-Versus-Leukemia"],"prefix":"10.1016","volume":"32","author":[{"given":"Niloufar Khayam","family":"Nekouei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8136-2251","authenticated-orcid":false,"given":"Negin","family":"Najjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Farajifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-1984","authenticated-orcid":false,"given":"Nafiseh","family":"Esmaeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Naseroleslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyar","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Behfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1228-1335","authenticated-orcid":false,"given":"Ali","family":"Ghamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Ali","family":"Hamidieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0001","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/bjh.16355","article-title":"The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience","volume":"188","author":"Loke","year":"2020","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.jtct.2025.12.991_bib0002","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41409-023-01943-3","article-title":"Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey","volume":"58","author":"Passweg","year":"2023","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2025.12.991_bib0003","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41423-025-01273-y","article-title":"Systematic mining and quantification reveal the dominant contribution of non-HLA variations to acute graft-versus-host disease","volume":"22","author":"Liang","year":"2025","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0004","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12935-024-03479-y","article-title":"Recent updates on allogeneic CAR-T cells in hematological malignancies","volume":"24","author":"Mansoori","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.991_bib0005","doi-asserted-by":"crossref","first-page":"e6799","DOI":"10.1002\/cam4.6799","article-title":"Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease","volume":"13","author":"Yue","year":"2024","journal-title":"Cancer Med"},{"issue":"18","key":"10.1016\/j.jtct.2025.12.991_bib0006","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.3390\/cells13181524","article-title":"Current approaches for the prevention and treatment of acute and chronic GVHD","volume":"13","author":"Olivieri","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtct.2025.12.991_bib0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajh.27593","article-title":"Toward improving initial therapy of acute graft versus host disease","volume":"100","author":"Mehta","year":"2025","journal-title":"Am J Hematol"},{"issue":"9674","key":"10.1016\/j.jtct.2025.12.991_bib0009","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"The Lancet"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.991_bib0010","doi-asserted-by":"crossref","first-page":"988.e1","DOI":"10.1016\/j.jtct.2021.08.021","article-title":"Evaluation of elafin as a prognostic biomarker in acute graft-versus-host disease","volume":"27","author":"Zewde","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0011","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.991_bib0012","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","article-title":"Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"21","author":"Arai","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.12.991_bib0013","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.jtct.2025.12.991_bib0014","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.3390\/cells13181524","article-title":"Current approaches for the prevention and treatment of acute and chronic GVHD","volume":"13","author":"Olivieri","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jtct.2025.12.991_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.605726","article-title":"GVHD prophylaxis 2020","volume":"12","author":"Gooptu","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jtct.2025.12.991_bib0016","doi-asserted-by":"crossref","first-page":"520","DOI":"10.6004\/jadpro.2023.14.6.5","article-title":"Post-transplant cyclophosphamide for the prevention of graft-vs.-host disease in allogeneic hematopoietic cell transplantation: a guide to management for the advanced practitioner","volume":"14","author":"Kachur","year":"2023","journal-title":"J Adv Pract Oncol"},{"key":"10.1016\/j.jtct.2025.12.991_bib0017","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJMoa2503189","article-title":"Graft-versus-host disease prophylaxis with cyclophosphamide and cyclosporin","volume":"393","author":"Curtis","year":"2025","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jtct.2025.12.991_bib0018","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.193.11.1311","article-title":"CD4+ CD25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade","volume":"193","author":"Taylor","year":"2001","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.991_bib0019","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/oncolo\/oyac076","article-title":"Recent FDA approvals in the treatment of graft-versus-host disease","volume":"27","author":"Martini","year":"2022","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.991_bib0020","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1634\/theoncologist.2019-0627","article-title":"FDA approval summary: ruxolitinib for treatment of steroid-refractory acute graft-versus-host disease","volume":"25","author":"Przepiorka","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.jtct.2025.12.991_bib0021","unstructured":"Wolf A MJ, Billings M. Novartis receives European Commission approval for Jakavi\u00ae to be the first post-steroid treatment for acute and chronic graft-versus-host disease. Jakavi (ruxolitinib) Summary of Product Characteristics. Novartis Pharma AG; 2022. Available from:https:\/\/www.novartis.com\/news\/media-releases\/novartis-receives-european-commission-approval-jakavi-be-first-post-steroid-treatment-acute-and-chronic-graft-versus-host-disease. Accessed February 2, 2026."},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41401-021-00641-4","article-title":"Regulatory T cells in ischemic stroke","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.991_bib0023","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.991_bib0024","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20020090","article-title":"CD4+ CD25+ immunoregulatory T cells: new therapeutics for graft-versus-host disease","volume":"196","author":"Cohen","year":"2002","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.991_bib0026","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/trf.16797","article-title":"Regulatory T cells: a review of manufacturing and clinical utility","volume":"62","author":"Mamo","year":"2022","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.991_bib0027","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.991_bib0028","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jtct.2025.12.991_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.926550","article-title":"Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease","volume":"13","author":"Hippen","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.991_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jgg.2024.09.014","article-title":"Improving regulatory T cell-based therapy: insights into post-translational modification regulation","volume":"52","author":"Wang","year":"2025","journal-title":"J Genet Genomics"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0031","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.991_bib0032","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2025.12.991_bib0033","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fimmu.2015.00493","article-title":"FOXP3(+) Treg cells and gender bias in autoimmune diseases","volume":"6","author":"Nie","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2025.12.991_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1291796","article-title":"Heterogeneity and subtypes of CD4+ regulatory T cells: implications for tumor therapy","volume":"14","author":"Lin","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jtct.2025.12.991_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1553554","article-title":"The distinctive signature of regulatory CD4 T cells committed in the human thymus","volume":"16","author":"Raposo","year":"2025","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.991_bib0037","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20091999","article-title":"TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo","volume":"207","author":"Gottschalk","year":"2010","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.991_bib0038","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1084\/jem.20040249","article-title":"In vivo instruction of suppressor commitment in naive T cells","volume":"199","author":"Apostolou","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtct.2025.12.991_bib0039","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fimmu.2013.00152","article-title":"Generation and function of induced regulatory T cells","volume":"4","author":"Schmitt","year":"2013","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.991_bib0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2009.05.002","article-title":"Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?","volume":"30","author":"Curotto de Lafaille","year":"2009","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.991_bib0041","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"issue":"5609","key":"10.1016\/j.jtct.2025.12.991_bib0042","first-page":"1057","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science (1979)"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.991_bib0043","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.991_bib0044","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.991_bib0045","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.4049\/jimmunol.1500703","article-title":"Phenotypic complexity of the human regulatory T cell compartment revealed by mass cytometry","volume":"195","author":"Mason","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2025.12.991_bib0046","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fimmu.2014.00046","article-title":"Regulatory T cells as immunotherapy","volume":"5","author":"Singer","year":"2014","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.991_bib0047","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3904\/kjim.2025.010","article-title":"Decreased frequency and inflammatory change of FoxP3+ regulatory T cells in immunopathogenesis of human acute graft-versus-host disease","volume":"40","author":"Seong","year":"2025","journal-title":"Korean J Intern Med"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.991_bib0048","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41409-025-02553-x","article-title":"Regulatory T cell therapy for graft-versus-host disease","volume":"60","author":"Lysandrou","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.12.991_bib0049","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.3389\/fimmu.2019.03100","article-title":"Treg heterogeneity, function, and homeostasis","volume":"10","author":"Shevyrev","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2025.12.991_bib0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of Treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.991_bib0051","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0052","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000526835","article-title":"Isolation and in vitro expansion of regulatory T cells from beta-thalassemia major kids and in vitro evaluation of their plasticity and inhibitory effects in the presence of pro-inflammatory cytokines","volume":"184","author":"Mansourabadi","year":"2023","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0053","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jtct.2025.12.991_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1387975","article-title":"Regulation of Treg cells by cytokine signaling and co-stimulatory molecules","volume":"15","author":"Zong","year":"2024","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.991_bib0055","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0056","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-\u03b2 regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.991_bib0057","first-page":"1155","article-title":"Transforming growth factor \u03b2 and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site","volume":"13","author":"Brabletz","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.991_bib0058","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4049\/jimmunol.158.3.1095","article-title":"TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action","volume":"158","author":"Nandan","year":"1997","journal-title":"J Immunol (Baltimore, MD: 1950)"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.991_bib0059","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.991_bib0060","doi-asserted-by":"crossref","first-page":"13293","DOI":"10.1080\/21655979.2022.2080367","article-title":"Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy","volume":"13","author":"Yan","year":"2022","journal-title":"Bioengineered"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.991_bib0061","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation\u2013mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.991_bib0062","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/intimm\/dxh207","article-title":"CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production","volume":"17","author":"Barthlott","year":"2005","journal-title":"Int Immunol"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.991_bib0063","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1073\/pnas.0812851107","article-title":"Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments","volume":"107","author":"Busse","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"10.1016\/j.jtct.2025.12.991_bib0064","doi-asserted-by":"crossref","first-page":"10468","DOI":"10.1073\/pnas.1201131109","article-title":"Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo","volume":"109","author":"Gotot","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.991_bib0065","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.4049\/jimmunol.0901163","article-title":"Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus","volume":"183","author":"Iikuni","year":"2009","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.991_bib0066","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","article-title":"IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis","volume":"185","author":"Yan","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.991_bib0067","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M","article-title":"Human CD4+ CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro","volume":"31","author":"Stephens","year":"2001","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0068","article-title":"Regulatory T cells: molecular actions on effector cells in immune regulation","volume":"2016","author":"Arce-Sillas","year":"2016","journal-title":"J Immunol Res"},{"issue":"5380","key":"10.1016\/j.jtct.2025.12.991_bib0069","first-page":"1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science (1979)"},{"issue":"24","key":"10.1016\/j.jtct.2025.12.991_bib0070","first-page":"3072","article-title":"Indoleamine 2, 3-dioxygenase in tumor induced tolerance","volume":"122","author":"Liu","year":"2009","journal-title":"Chin Med J (Engl)"},{"issue":"204","key":"10.1016\/j.jtct.2025.12.991_bib0071","doi-asserted-by":"crossref","first-page":"ra90","DOI":"10.1126\/scisignal.2002179","article-title":"Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-\u03baB, and NFAT signaling in conventional T cells","volume":"4","author":"Schmidt","year":"2011","journal-title":"Sci Signal"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0072","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+ CD25+ CD127\u2212 T regulatory cells","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.991_bib0073","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1182\/bloodadvances.2020003219","article-title":"First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings","volume":"5","author":"MacMillan","year":"2021","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.991_bib0074","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood\u2013derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.jtct.2025.12.991_bib0075","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood-2014-10-603449","article-title":"Ex vivo fucosylation of third-party human regulatory T cells enhances anti\u2013graft-versus-host disease potency in vivo","volume":"125","author":"Parmar","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.12.991_bib0076","doi-asserted-by":"crossref","DOI":"10.3389\/frtra.2024.1448650","article-title":"Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes","volume":"3","author":"Zeng","year":"2024","journal-title":"Front Transplant"},{"issue":"14","key":"10.1016\/j.jtct.2025.12.991_bib0077","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.991_bib0078","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.991_bib0079","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1078-0432.CCR-13-3205","article-title":"Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity","volume":"20","author":"Kennedy-Nasser","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.991_bib0080","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/bloodadvances.2020003739","article-title":"Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia","volume":"5","author":"Pierini","year":"2021","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.991_bib0081","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.991_bib0082","doi-asserted-by":"crossref","first-page":"eadf0567","DOI":"10.1126\/sciadv.adf0567","article-title":"Inflammatory CD4\/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology","volume":"9","author":"Hess","year":"2023","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.991_bib0083","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jcyt.2014.11.005","article-title":"Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease","volume":"17","author":"Theil","year":"2015","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jtct.2025.12.991_bib0084","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1600-6143.2011.03558.x","article-title":"Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease","volume":"11","author":"Hippen","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jtct.2025.12.991_bib0085","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720923578","article-title":"A comparison of automated perfusion-and manual diffusion-based human regulatory T cell expansion and functionality using a soluble activator complex","volume":"29","author":"Jones","year":"2020","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jtct.2025.12.991_bib0086","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fimmu.2019.00038","article-title":"Automated clinical grade expansion of regulatory T cells in a fully closed system","volume":"10","author":"Mar\u00edn Morales","year":"2019","journal-title":"Front Immunol"},{"issue":"48","key":"10.1016\/j.jtct.2025.12.991_bib0087","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.13101","article-title":"Utilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders","volume":"7","author":"Go\u0142\u0105b","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0088","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1038\/s41598-018-25574-7","article-title":"A phase I clinical trial with ex vivo expanded recipient regulatory T cells in living donor kidney transplants","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0089","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2007-06-094482","article-title":"Differential impact of mammalian target of rapamycin inhibition on CD4+ CD25+ Foxp3+ regulatory T cells compared with conventional CD4+ T cells","volume":"111","author":"Zeiser","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.991_bib0090","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.991_bib0091","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood-2004-01-0086","article-title":"Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells","volume":"104","author":"Hoffmann","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.991_bib0092","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jcyt.2021.02.118","article-title":"Multiply restimulated human thymic regulatory T cells express distinct signature regulatory T-cell transcription factors without evidence of exhaustion","volume":"23","author":"Hippen","year":"2021","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.991_bib0093","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138519","article-title":"Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis","volume":"131","author":"Pompura","year":"2021","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.991_bib0094","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1600-6143.2007.02088.x","article-title":"Ex vivo-expanded natural CD4+ CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts","volume":"8","author":"Xia","year":"2008","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.991_bib0095","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/bloodadvances.2019001248","article-title":"IL-2 enhances ex vivo\u2013expanded regulatory T-cell persistence after adoptive transfer","volume":"4","author":"Furlan","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0096","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.exphem.2005.10.011","article-title":"Tolerance induction by third-party \u201coff-the-shelf\u201d CD4+ CD25+ Treg cells","volume":"34","author":"Steiner","year":"2006","journal-title":"Exp Hematol"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.991_bib0097","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/ajt.13725","article-title":"Ex vivo costimulatory blockade to generate regulatory T cells from patients awaiting kidney transplantation","volume":"16","author":"Guinan","year":"2016","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.991_bib0098","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/ajt.16842","article-title":"Ex vivo generation of regulatory T cells from liver transplant recipients using costimulation blockade","volume":"22","author":"Shimozawa","year":"2022","journal-title":"Am J Transplant"},{"issue":"15","key":"10.1016\/j.jtct.2025.12.991_bib0099","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2016-09-741629","article-title":"PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy","volume":"129","author":"Asano","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.991_bib0100","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.bbmt.2020.08.034","article-title":"Clinical-grade expanded regulatory T cells are enriched with highly suppressive cells producing IL-10, granzyme B, and IL-35","volume":"26","author":"Ulbar","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.991_bib0101","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/blood-2015-12-684142","article-title":"Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD","volume":"128","author":"Matta","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.991_bib0102","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.7150\/thno.30254","article-title":"Human LAP(+)GARP(+)FOXP3(+) regulatory T cells attenuate xenogeneic graft versus host disease","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.991_bib0103","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1084\/jem.20141528","article-title":"Adenosine signaling promotes hematopoietic stem and progenitor cell emergence","volume":"212","author":"Jing","year":"2015","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.991_bib0104","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2011.09.053","article-title":"Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche","volume":"147","author":"Yamazaki","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.991_bib0105","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.991_bib0106","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.991_bib0107","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","article-title":"Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.12.991_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101803","article-title":"T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia","volume":"77","author":"Bayegi","year":"2023","journal-title":"Transpl Immunol"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.991_bib0109","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jtct.2025.12.991_bib0110","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0111","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.991_bib0112","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbmt.2013.10.022","article-title":"Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression","volume":"20","author":"Sawitzki","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.12.991_bib0113","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/bloodadvances.2020003272","article-title":"Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD","volume":"5","author":"Hirai","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.12.991_bib0114","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716629","article-title":"Cyclosporine a but not corticosteroids support efficacy of ex vivo expanded, adoptively transferred human Tregs in GVHD","volume":"12","author":"Landwehr-Kenzel","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.jtct.2025.12.991_bib0115","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1182\/blood.2022018440","article-title":"Prevention of acute GVHD using an orthogonal IL-2\/IL-2R\u03b2 system to selectively expand regulatory T cells in vivo","volume":"141","author":"Ramos","year":"2023","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.991_bib0116","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/bloodadvances.2023011625","article-title":"Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD","volume":"8","author":"Bader","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.991_bib0117","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127244","article-title":"Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients","volume":"4","author":"Meyer","year":"2019","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.jtct.2025.12.991_bib0118","article-title":"Tipping the GVH\/GVL balance by targeting HIF1\u03b1","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.991_bib0119","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10238-025-01588-0","article-title":"Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets","volume":"25","author":"Raoufi","year":"2025","journal-title":"Clin Exp Med"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.991_bib0120","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/s41375-023-01932-x","article-title":"A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect","volume":"37","author":"Guardalupi","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2025.12.991_bib0121","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fimmu.2020.00181","article-title":"Interleukin-27 enforces regulatory T cell functions to prevent graft-versus-host disease","volume":"11","author":"Le","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.991_bib0122","doi-asserted-by":"crossref","first-page":"341.e1","DOI":"10.1016\/j.jtct.2023.02.015","article-title":"Treg amelioration of GVHD following allo\/xeno-HSCT using mobilized mouse and human peripheral blood donors","volume":"29","author":"Barreras","year":"2023","journal-title":"Transplant Cell Ther"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725026545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725026545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:07:20Z","timestamp":1780312040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725026545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":122,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666636725026545"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.991","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tregs in Allogeneic Hematopoietic Stem Cell Transplantation: Suppressing Graft-Versus-Host Disease while Preserving Graft-Versus-Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}